Certain A Shares of Shanghai Labway Clinical Laboratory Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-SEP-2023. These A Shares will be under lockup for 738 days starting from 6-SEP-2021 to 14-SEP-2023.

Details:
The company?s holding shareholder Shanghai Labway Investment Co., Ltd, actual controllers Zeng Weixiong, Jing Huijuan, shareholder Shanghai Huikun Investment Management Center (Limited Partnership) promised that, within 36 months after the listing date, will not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. After the expiration of the lockup period, during the term of office as the company?s director, supervisor or management personnel, the number of shares in the company transferred each year will not exceed 25% of the total shares held in the company. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period will automatically be extended for 6 months.

Other directors, supervisors, management personnel promised that, within 12 months after the listing date and half year from resignation, will not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares. After the expiration of the lockup period, during the term of office as the company?s director, supervisor or management personnel, the number of shares in the company transferred each year will not exceed 25% of the total shares held in the company. If the closing price of the company?s share is lower than the issue price for 20 consecutive trading days within 6 months after listing, or if the closing price of the company?s share is lower than the issue price for the period ending six months after listing, then the lockup period will automatically be extended for 6 months.

Shareholders Heilan Group Co., Ltd. Shanghai Bozhi Fangde Investment Center (Limited Partnership) and Hunan Tianxun Bozhi Investment Partnership Enterprise (Limited Partership), Other founding shareholders Duan Dayou, Sun Linjie, Yang Jing, Yuan Hong and Other shareholders promised that, within 12 months after the listing date, will not transfer nor entrust to others for management direct or indirect shares in the company held prior to this issuance, nor allow the company to repurchase the said shares.